Brian Hughes
Seminars
Wednesday 30th September 2026
Objective Cough Monitoring in IPF/ILD: Assessing Symptomatic Treatment Benefit
1:00 pm
- Cough is a high-burden but inconsistently captured symptom in IPF/ILD. Patient-reported measures and clinical assessments don’t fully capture the day-to-day impact and variability of cough
- C-mo provides continuous, objective cough monitoring in patients’ everyday environments. This passive biosensor based measurement can complement established endpoints with a quantifiable respiratory symptom signal
- C-mo is a validated, CE-marked platform built for clinical research. It supports reliable cough data collection, with the potential to strengthen symptomatic-efficacy evidence and reduce reliance on burdensome manual reporting
